Member Info for Thompi

Chris,

I would be very surprised if CC isn’t at the AGM.

The AGM is one of the most important opportunities of the year for shareholders to hear directly from the board and, with AVA6000, AVA6103 and partnership discussions all in focus, I would expect the CEO to be front and centre.

BIO may create a diary clash, but the conference runs over several days and I’d imagine the company will have planned around both events. If CC were unable to attend, I suspect shareholders would be informed in advance given the number travelling to London specifically for the AGM.

I’m attending myself and it involves a three-hour train journey each way, plus a hotel stay, so it’s not an insignificant commitment.

My assumption is that she’ll be there unless the company says otherwise.

Touk - you complain that posters on here can be abusive at times. Yet you write two posts that are designed to be provocatively mocking and likely to illicit a reaction. Not your best move.

Https://x.com/sandyradders/status/2065782152713716144?s=61&t=BBb2UcjLDTXOFIzJM-vM6A

A good couple of posts on X from Cumulus and Radders re the speed AVA6103 went through development to clinic.

Hi BV,

Chris also said this in the prelims presentation regarding the AVA6000 data that would be released at either ASCO or BIO:

“We will also include some of the biopsy data. We have discussed previously that the biopsy data in patients is really some of what led to our ability to develop that sustained release mechanism.”

Given that ASCO was largely focused on the safety, cardiac and SGC data, I wonder whether some of the biopsy data Chris referred to might be reserved for BIO.

I don’t know why the AGM is being held before BIO, BV.

I’m attending the AGM and, from a shareholder’s perspective, it would have been useful to see any BIO-related data releases beforehand. I suspect there may be a number of AVA6000 questions that attendees would like to ask, but Chris may be unable to answer them if the data has not yet been made public.

Unless, of course, there is an RNS on the morning of the AGM.

There will most likely be a business update at 7:00am, as there has been in each of the previous two years before the AGM, so perhaps that may provide some additional context.

Many a true word is said in jest. I’m looking forward to this year’s AGM without the CLN being a dominating issue.

https://x.com/sandyradders/status/2063989287289299060?s=61

Shame there isn’t a cure, PL75, for getting rid of Thorn’s latest reincarnation as Teabag and his malicious posts.

What I genuinely don’t understand is why people repeatedly post about a share they’re not invested in. I thought we’d finally seen the back of Thorn and his record of 41 posts in 24 hours. That would have been a bit odd even for someone who held the shares, but for someone with no investment at all it’s just bizarre.

I really have to bite my tongue because he really winds me up. I tried filtering him last year but I could still see the replies to him.

Teabag/Thorn are you invested in Avacta? And if not then what is your motivation for posting on this board?

Touk, the reference was not from December 2025. If you read my post properly you will see that I clearly said it was from the prelims presentation - which was last month.

I included the link - and I will attach it again for you. It was approximately 50 minutes into the presentation.

https://www.investormeetcompany.com/meetings/preliminary-results-88

Sorry about the formatting - LSE goes off on a wobbly sometimes.

Ben, I think I can answer Touk’s question to you about the NDA reference.

It was approximately 50 minutes into the prelims presentation.

“It’s also important to note that we do also have substantive conversations with a number of partners that are under confidential nondisclosure agreements across different assets. These discussions, I would

describe them as constructive. They are progressing. But given the NDAs that are in place, it

wouldn't be appropriate for me to speculate on any kind of status beyond saying that we do

have a clear business development plan that we are executing”.

https://www.investormeetcompany.com/meetings/preliminary-results-88

I was going for alliteration but for some reason LSE allows twat but not to-sser. Having put up with Thorn for years, please the god of LSE remove his reincarnation - Teabag.

teabag=thorn=******=transparent=twat.

Tim, I still look book at the good old days (somtime earlier this year) when Thorn was in his pomp(ous) twat best. Will we ever see the like again (take note Teabag) with his 41 posts in one day? An absolute fud-fest classic. Some record - I don’t think it will ever be beaten even by the combined “to me to you” tag team.

I’m almost feeling nostalgic…

Nice little video clip of Alex Spira from SD posted by Sandy on X.

ADC’s have dominated, understandably the headlines, but they have side effects which also limits their MTD. AVA6103 offers differentiation - “a unique entity and moeity” were the words he used, if I have remembered correctly.

https://x.com/sandyradders/status/2059685941367709923?s=12

Thanks BV & Opti for the Science Day feedback - it’s very much appreciated.

For some reason LSE seems to remove any capital letters if you use a word they don’t like. I should have just used Thorn the twat…

yes, there are some tells with teabag/thorn - like the questions.

but you have to pump up the volume with the posts. thornogson set the bar high - will the record 41 posts in twenty-four hours ever be beaten? i doubt it - the ******.

Thanks BV for pointing that out - it’s easy to let our enthusiasm run away with us sometimes, but you are right that the “new site” was already referenced back in March.

Interesting though that, according to comments from the Science Day shared on X, the company plans to expand to around 8 sites for Phase 1a and potentially up to 20 for the next stage.

Unlikely Wyn that RH could have flipped his placing. Under UK MAR, the PDMR disclosure threshold is €5,000 aggregate transactions within a calendar year. RH, as a NED, falls within those rules.

We have had no announcements indicating he has sold.

https://www.fca.org.uk/publications/newsletters/primary-market-bulletin-issue-no-30